編號,通報時間,中文品名,英文品名,許可證字號,成分學名,劑型劑量,許可證持有藥商,短缺原因,預估解決時間,備註
"1","2012","成分：PSEUDOEPHEDRINE","未說明","未說明","PSEUDOEPHEDRINE","x","未說明","局長信箱通報","有同成份替代藥品使用，暫無醫療上問題。",""
"2","2012","硫酸阿托品點眼液０．５％","ATROPINE SULPHATE OPHTHALMIC SOLUTION 0.5%","衛署藥製字第032058號","ATROPINE SULFATE","1 MG/ML","五福化學製藥股份有限公司　","PICS查廠","已恢復供貨",""
"3","2012","腸寶錠","CHANPON TABLETS","衛署藥製字第009638號","MEPENZOLATE BROMIDE","15 MG","永昌藥品股份有限公司","廠商缺貨","已恢復供貨",""
"4","2012","法布瑞酉每凍晶注射劑","FABRAZYME INJECTION","罕菌疫輸字第000005號","AGALSIDASE BETA","35MG/ VIAL","賽諾菲股份有限公司","因製造廠變更暫時缺貨","已恢復供貨",""
"5","2012","庫魯化錠８５０毫克","GLUCOPHAGE TABLET 850MG","衛署藥輸字第018231號","","850MG","嘉德藥品企業股份有限公司","廠商缺貨","已恢復供貨",""
"6","2012","克焦慮錠","KALMA TABLETS","衛署藥輸字第021035號","ALPRAZOLAM","0.25MG、0.5MG、1MG","海喬國際股份有限公司","廠商缺貨","已恢復供貨",""
"7","2012","吉多利錠　","KETOSTERIL TABLETS　","衛署藥輸字第018273號","L-HISTIDINE, L-LYSINE ACETATE, L-THREONINE, L-TRYPTOPHAN, L-TYROSINE, CALCIUM-3-METHYL-2-OXO-VALERATE, CALCIUM-4-METHYL-2-OXO-VALERATE, CALCIUM-3-METHYL-2-OXO-BUTYRATE, CALCIUM-2-OXO-3-PHENYL-PROPIONATE, CALCIUM-DL-2-HYDROXY-4-(METHYL-THIO)-BUTYRATE","x","臺灣費森尤斯卡比股份有限公司","廠商缺貨","已恢復供貨",""
"8","2012","敏立舒注射液","MILLISROL INJECTION　","衛署藥輸字第018979號","NITROGLYCERIN","10ML、100ML","臺灣日化股份有限公司　","製造廠出貨延遲","已恢復供貨",""
"9","2012","滅菌靈懸液","Mycostatin Oral Suspension","衛署藥製字第034904號","NYSTATIN","24ML","臺灣必治妥施貴寶股份有限公司","廠商停售","有同成份替代藥品使用，暫無醫療上問題。","經查相同成分許可證廠商：中美、元宙、井田、永信、輝瑞；或以Nystatin 500,000u/cap替代，國內尚有膠囊、錠劑之同成分產品可供直接吞服或磨碎泡水來替代使用。"
"10","2012","耐適恩錠２０公絲","NEXIUM TABLETS 20MG","衛署藥輸字第023225號","ESOMEPRAZOLE MAGNESIUM TRIHYDRATE","20MG","臺灣阿斯特捷利康股份有限公司","廠商缺貨","已恢復供貨",""
"11","2012","保乳調錠","PARLODEL TABLETS","衛署藥製字第030882號","BROMOCRIPTINE MESILATE","2.5MG","臺灣諾華股份有限公司","主成分原料短缺","有同成份替代藥品使用，暫無醫療上問題。","經查相同成分許可證廠商：信東、長安、華興、井田、永信、瑞士、瑞人、國嘉、中化、內外、吉富、衛達、信東、中日、北進"
"12","2012","速復滴劑　","SOFRADEX DROPS","衛署藥輸字第021518號","FRAMYCETIN (SULFATE) SOFRAMYCIN(SULFATE), DEXAMETHASONE SODIUM SULFOBENZOATE M-, GRAMICIDIN","8ML","賽諾菲股份有限公司","製造廠供貨不及","已恢復供貨",""
"13","2012","石立消膠囊250毫克","SULISOU CAPSULES 250MG","衛署藥製字第031953號","CHENODEOXYCHOLIC ACID","250MG","國嘉製藥工業股份有限公司　","原料短缺暫時缺貨","已恢復供貨",""
"14","2012","吸必擴都保定量粉狀吸入劑 320/9 μG/DOSE","SYMBICORT TURBUHALER 320/9 μG/DOSE","衛署藥輸字第023980號","FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE","320/9μG","臺灣阿斯特捷利康股份有限公司","廠商缺貨","已恢復供貨",""
"15","2012","泰寧注射劑　","TIENAM INJECTION","衛署藥輸字第019279號","IMIPENEM, CILASTATIN","250MG、500MG","美商默沙東藥廠股份有限公司台灣分公司","製造廠出貨延遲","已恢復供貨",""
"16","2012","優達命注射液","UTAMINE INJECTION","衛署藥製字第038707號","DOBUTAMINE","20ML","優良化學製藥股份有限公司","廠房改建導致無法供貨","有同成份替代藥品使用，暫無醫療上問題。","經查相同成分許可證共七家廠商"
"17","2012","黴飛凍晶注射液200公絲","VFEND 200MG FOR SOLUTION FOR INFUSION","衛署藥輸字第023648號","VORICONAZOLE","200MG","輝瑞大藥廠股份有限公司","製造廠出貨延誤","已恢復供貨",""
"18","2012","維他命乙複方糖衣錠","VITAMIN B COMPLEX S.C. TABLETS ＂Y.C.＂","衛署藥製字第033182號","NIACINAMIDE (NICOTINAMIDE), THIAMINE (VITAMIN B1), RIBOFLAVIN (VIT B2), VITAMIN B6 (HCL FROM YEAST CONC.), CYANOCOBALAMIN (VIT B12), PANTOTHENATE CALCIUM","x","元宙化學製藥股份有限公司","廠商缺貨","已恢復供貨",""
"19","2012","樂無喘凍晶注射劑150毫克","Xolair 150 mg powder and solvent for solution for injection","衛署菌疫輸字第000835號","OMALIZUMAB","150MG","台灣諾華股份有限公司","製造廠出貨延誤","已恢復供貨",""
"20","2012","利達 寧神平注射液","DIAZEPAM INJECTION ＂LITA＂","衛署藥製字第010547號","DIAZEPAM","2 ML","利達製藥股份有限公司","原廠無法供貨","經評估國內無替代藥品，已徵得有意願供應之藥商","有廠商協助專案進口"
"22","2012","利達平注射劑","RETARPEN","衛署藥輸字第016989號","PENICILLIN G BENZATHINE LECITHINIZED","2.4 MIU","創富國際有限公司","原廠停產","經評估國內無替代藥品，已徵得有意願供應之藥商","有廠商協助專案進口"
"23","2012","戒酒發泡錠","Antabus","專案進口藥品","","x","專案進口藥品","原協助專案進口支廠商不再代理","經評估後建議使用替代藥品：Naltrexone、Acamprosate、Nalmefene、Topiramate、Baclofen、SSRI類、Ondansetron等","有不同成份替代藥品使用，暫無醫療上問題。"
"21","2012","痡路摩閃爍ＴＣ９９Ｍ注射劑","PULMOLITE TECHNETIUM TC99M AGGREGATED ALBUMIN KIT STERILE DIAGNOSTIC FOR INTRAVENOUS USE","衛署藥輸字第R00076號","ALBUMIN HUMAN, ALBUMIN","x","昶洋貿易股份有限公司","原廠停產","經評估國內無替代藥品，已徵得有意願供應之藥商","有廠商協助專案進口"
"24","2012","易莎平注射劑","IXEMPRA for Injection","衛署藥輸字第025053號","IXABEPILONE","15MG、/45MG","臺灣必治妥施貴寶股份有限公司","廠商停產","經評估後建議使用替代藥品：(1)GEMCITABINE HCl；(2)CAPECITABINE","有不同成份替代藥品使用，暫無醫療上問題。(東洋、禮來、藥華、神隆、費森尤斯卡比、赫士睿、羅氏)"
"25","2012","磷酸鉀注射液","POTASSIUM PHOSPHATE INJECTION ＂U.L.＂","衛署藥製字第021343號","POTASSIUM PHOSPHATE","20 ML","優良化學製藥股份有限公司","廠商停產","經評估後建議使用替代藥品：SODIUM PHOSPHATE DIBASIC ANHYDROUS","有不同成份替代藥品使用，暫無醫療上問題。(停產藥品)"
"26","2012","保樂胎蒙戊錠","Prostarmon-E","衛署藥製字第041249號","DINOPROSTONE BETA- CYCLODEXTRIN","0.5MG","仁興化學製藥股份有限公司","廠商缺貨","經評估後建議使用替代藥品：(1)DINOPROSTONE(2) Oxytocin","有不同成份替代藥品使用，暫無醫療上問題(輝瑞PROSTIN、 東洲Oxytocin"
"27","2012","利甫蓋素濃縮注射液","REPLAGAL","罕菌疫輸字第000004號","AGALSIDASE ALFA","3.5ml","科懋生物科技股份有限公司","藥證變更","經評估後建議使用替代藥品：AGALSIDASE","有不同成份替代藥品使用，暫無醫療上問題(賽諾菲FABRAZYME)"
"28","2012","治疥芬軟膏","SCALPHEN OINTMENT (MESULPHEN)","衛署藥製字第019422號","MESULPHEN","330MG/G","杏輝藥品工業股份有限公司","廠商停產","經評估後建議使用替代藥品：HYDROCORTISONE,CROTAMITON","有不同成份替代藥品使用，暫無醫療上問題(杏輝)"
"29","2012","明礬沉澱破傷風類毒素、吸著破傷風白喉混合類毒素(成人用)、吸著白喉破傷風混合類毒素","Tetanus Toxoid Alum Precipitated、 Tetanus & Diphtheria Toxoids Adsorbed（Adult Use）、Diphtheria & Tetanus Toxoids Adsorbed","衛署菌疫製字第000048號、衛署菌疫製字第000088號、衛署菌疫製字第000020號","TETANUS TOXOID、DIPHTHERIA TOXOID、DIPHTHERIA TOXOID","1ML、3MG","疾病管制局","硬體老舊，無法符合法規規定，101年起不再生產","經評估後建議使用替代藥品：TETANUS TOXOID ，後兩種預計102年下半年可生產出貨","有不同成份替代藥品使用，暫無醫療上問題。(停產藥品)"
"30","2013.01","艾黴素注射劑１０公絲　〝速溶〞","ADRIBLASTINA RD","衛署藥輸字第018580號","DOXORUBICIN HCL","10MG/注射劑","輝瑞大藥廠","製造廠產程安排不及，致暫時缺貨","有同成份替代藥品使用，暫無醫療上問題。","經查該成分許可證廠商：費森由斯卡比、聯邦、海喬"
"31","2013.01","安保寧錠２毫克","APO-HALOPERIDOL 2MG TABLETS　","衛署藥輸字第019501號","HALOPERIDOL","2MG","鴻汶醫藥實業有限公司","廠商無法供貨","有同成份替代藥品使用，暫無醫療上問題。","經查該成分許可證約有20家廠商"
"32","2013.01","25%人體正常血清白蛋白注射劑　","BUMINATE 25% ALBUMIN (HUMAN) USP, 25% SOLUTION","衛署菌疫輸字第000271號","ALBUMIN HUMAN NORMAL SERUM","50ml","百特醫療產品股份有限公司　","廠商無法供貨","有同成份替代藥品使用，暫無醫療上問題。","經查該成分許可證廠商如下：天行、世信、吉發、綠十字、輔凱"
"33","2013.01","可氯松眼藥膏","CHLORSON EYE OINTMENT ＂OASIS＂","衛署藥製字第022920號","CHLORAMPHENICOL, HYDROCORTISONE ACETATE","3.5MG","綠洲化學工業有限公司","廠商因興建新廠缺貨","已恢復供貨",""
"34","2013.01","康體邁新眼藥膏","CODEMYCIN EYE OINTMENT","衛署藥製字第003969號","NEOMYCIN (SULFATE), HYDROCORTISONE ACETATE","3.5MG","綠洲化學工業有限公司","廠商因興建新廠缺貨","已恢復供貨",""
"35","2013.01","福喜顆粒","FLUCIL GRANULE","衛署藥製字第032323號","ACETYLCYSTEINE","40MG/GM","瑞安藥廠","廠商缺貨","有同成份替代藥品使用，暫無醫療上問題。","經查有多家相同成分許可證藥商"
"36","2013.01","維他命Ａ眼藥膏","VITA A EYE OINTMENT","衛署藥製字第004156號","VITAMIN A","3.5MG","綠洲化學工業有限公司","廠商因興建新廠缺貨","已恢復供貨",""
"37","2013.01","排多癌注射劑１０公絲","MITOMYCIN-C KYOWA 10MG","衛署藥輸字第021026號","MITOMYCIN C","10MG","台灣協和醱酵其林股份有限公司","廠商缺貨","可查閱http://www.pharmaceutic.idv.tw/2012_lm/news_list.php?mid=26","有不同成份替代藥品使用，暫無醫療上問題。"
"38","2013.01","新定康癬膠囊１０毫克","NEOTIGASON CAPSULES 10MG","衛署藥輸字第022118號","ACITRETIN","10MG","臺灣美強股份有限公司","廠商臨時缺藥","經評估後建議使用不同成分替代藥品：(1)Methotrexate(2)Cyclosporine(3)Acitretin 25mg/cap","有不同成份替代藥品使用，暫無醫療上問題。"
"63","2013.06.13","魯格爾試劑","lugol sol’n","無","-","無","無","國內無藥證","國內目前並無藥廠製造或是代理商進口相關魯格爾製劑，亦無相關藥證。已徵得有意願供應之藥商","有廠商協助專案進口"
"65","2013.06.27","活寧液","FORANE (ISOFLURANE)","衛署藥輸字第013161號","ISOFLURANE","","美商亞培股份有限公司台灣分公司","製造廠延遲出貨","有同成份替代藥品使用，暫無醫療上問題。","生產廠商：瑞帝、寶齡富錦"
"73","2013.07.24","普栓達膠囊110、150毫克","Pradaxa Capsules","衛署藥輸字第025458號、025459號","DABIGATRAN ETEXILATE MESILATE","110MG/150MG","臺灣百靈佳殷格翰股份有限公司","原廠短缺","已恢復供貨","102/11聯繫，百靈佳供貨無虞"
"107","2013.12.03","好度注射液","HALDOL INJECTION","衛署藥輸字第019338號","HALOPERIDOL","5MG/ML","嬌生股份有限公司","製造廠產能問題，2014年中以前可能有供貨短缺之問題","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","供應廠商：瑞士、汎生"
"39","2013.01","硝基？喃妥因錠","NITROFURANTOIN TABLETS ＂Y.S.＂","衛署藥製字第003403號","NITROFURANTOIN","100MG/TAB","優生製藥廠(股)","原料缺貨中，致暫時缺貨","經評估後建議使用替代藥品：(1) Amoxicillin (2)Baktar","有不同成份替代藥品使用，暫無醫療上問題(信東Amoxicillin 、鹽野義Baktar)"
"40","2013.02","移黏寶酶靜脈輸液","ELAPRASE (idursulfase) Injection　","罕菌疫輸字第000011號","IDURSULFASE","x","賽諾菲股份有限公司","因外包裝變更無法進貨","已恢復供貨","102/11聯繫，賽諾菲供貨無虞"
"41","2013.02","若克瘤注射液１０公絲？公撮","LEUCOVORIN 10MG/ML INJECTION","衛署藥輸字第020935號","FOLINATE CALCIUM 5H2O","10MG","海喬國際股份有限公司","原料短缺暫時缺貨","有同成份替代藥品使用，暫無醫療上問題。","102/11聯繫，諾華供貨無虞"
"42","2013.02","若克瘤注射劑５０公絲　","LEUCOVORIN CALCIUM FOR INJECTION 50MG/VIAL","衛署藥輸字第020789號","FOLINATE CALCIUM 5H2O","50MG","海喬國際股份有限公司","原料短缺暫時缺貨","有同成份替代藥品使用，暫無醫療上問題。","102/11聯繫，諾華供貨無虞"
"43","2013.02","硫酸魚精蛋白注射液","PROTAMINE SULPHATE LEO PHARMA 1400 ANTI-HEPARIN IU/ML SOLUTION FOR INJECTION AND INFUSION","衛署藥輸字第012640號","PROTAMINE SULFATE","5 ML","禾利行股份有限公司","原料短缺暫時缺貨","已恢復供貨","102/11聯繫，禾利行供貨無虞"
"44","2013.02","爾可甦凍晶注射劑５０公絲","RESCUVOLIN 50MG","衛署藥輸字第011229號","FOLINATE ( AS CALCIUM)","50MG","民橋企業股份有限公司","原料短缺暫時缺貨","經評估國內無替代藥品，已徵得有意願供應之藥商","有廠商協助專案進口(供應者:諾華)"
"45","2013.02","必除癌注射液２５公絲／公撮","ABITREXATE INJECTION, 25MG/ML","衛署藥輸字第020808號","METHOTREXATE","25MG","海喬國際股份有限公司","製造廠產能縮減暫時無法供貨","有許可證廠商恢復供貨","供貨廠商:赫士睿、諾華"
"46","2013.02","易滅得庇福注射液２５公絲？公撮","EMTHEXATE PF","衛署藥輸字第008859號","METHOTREXATE (SODIUM)","25MG","民橋企業股份有限公司","製造廠產能縮減暫時無法供貨","經評估國內無替代藥品，已徵得有意願供應之藥商","供貨廠商:赫士睿、諾華"
"47","2013.02","得賜滿注射液","DESMAN INJECTION","內衛藥製字第002342號","IRON DEXTRAN","2 ML","應元化學製藥股份有限公司","廠商通知缺貨","經評估後建議使用替代藥品：FERRIC-HYDROXIDE-SUCROSE(南光FE-BACK INJECTION)","有替代藥品使用，暫無醫療上問題(南光FE-BACKINJECTION)。"
"48","2013.02","干適能錠　 　","HEPSERA TABLETS","衛署藥輸字第023920號","ADEFOVIR DIPIVOXIL","10 MG","荷商葛蘭素史克藥廠股","因廠商國外生產線整合以致供貨不足","經評估後建議使用替代藥品：ENTECAVIR","有不同成份替代藥品使用，暫無醫療上問題(中化 Envir F.C.、必治妥Baraclude)。"
"49","2013.03","史帝富 保麗娜液","POLYTAR LIQUID","衛署藥輸字第018134號","POLYTAR BLEND","150 mL/bot","荷商葛蘭素史克藥廠股","廠商國外生產線整合","經評估後建議使用同適應症替代藥品：抗組織胺內外用藥、固醇類製劑、免疫抑制劑、維生素A、D類藥品等等","有不同成份替代藥品使用，暫無醫療上問題。"
"50","2013.03","史帝富普麗液","POLYTAR EMOLLIENT","衛署藥輸字第018428號","PINE TAR, TAR B.P., POLYTAR BLEND, ARACHIS OIL, EXTRACT OF COAL TAR, ARACHIS OIL EXTRACT OF CRUDE COAL TAR, COAL TAR, COAL TAR SOLUTION, JUNIPER OIL (CADE OIL)","350 mL/bot","荷商葛蘭素史克藥廠股","廠商國外生產線整合","經評估後建議使用同適應症替代藥品：抗組織胺內外用藥、固醇類製劑、免疫抑制劑、維生素A、D類藥品等等","有不同成份替代藥品使用，暫無醫療上問題。"
"51","2013.04","艾德酶靜脈注射用溶液","Aldurazyme Concentrated Solution","罕菌疫輸字第000007號","LARONIDASE","x","賽諾菲股份有限公司","原製造廠斷貨","有同成份替代藥品使用，暫無醫療上問題。","品名：Aldurazyme Concentrated Solution (賽諾菲)，製造廠不同"
"52","2013.04","柔他益持續性膜衣錠","FINSKA-LP S.R.F.C. TABLETS　","衛署藥製字第044277號","LORATADINE, PSEUDOEPHEDRINE SULFATE","5MG/120 MG複方","中國化學製藥股份有限公司新豐工廠","該品項因疾管局控管原料，導致原料缺貨，暫時無法供貨","有同成份替代藥品使用，暫無醫療上問題。","廠商：默沙東、永信、十全"
"53","2013.04","愛泌羅膠囊１００公絲","ELMIRON CAPSULES 100MG","衛署藥輸字第023657號","SODIUM PENTOSAN POLYSULPHATE","100MG","弘如洋生技股份有限公司","廠商停止代理","經評估後建議使用同適應症替代品項：Sodium Hyaluronate (11/12更新:此藥品於102/07開始已有許可證可供應:衛署藥製字第057862號)，暫無醫療上問題。","另有AMITRIPTYLINE、Hydroxyzine為off label use，Sodium Hyaluronate為醫材之膀胱內灌注液 (11/12更新:藥品名稱「優而順膠囊」,衛署藥製字第057862)"
"55","2013.08","有利癌","FLUORO-URACIL VALEANT","衛署藥輸字第023404號","FLUOROURACIL","","新加坡商美納里尼醫藥有限公司台灣分公司","廠商無法供貨","已恢復供貨",""
"56","2013.08","服樂癌注射液５０公絲∕公撮","FLUOROURACIL INJECTION 50MG/M","衛署藥輸字第020807號","FLUOROURACIL","5ML/10ML/25ML","海喬國際股份有限公司","廠商無法供貨","有同成份替代藥品使用，暫無醫療上問題。(衛部藥製字第058033號可供應)",""
"57","2013.09","可美淨凍晶注射劑","COSMEGEN LYOPHILIZED POWDER FOR INJECTION","衛署藥輸字第019289號","DACTINOMYCIN","x","香港商英維達有限公司台灣分公司","因原廠通知將終止該公司代理，其代理銷售到今年12月31日","醫院有需求者，請洽詢意願廠商吉帝公司。",""
"61","2013.05.24","化痰能膠囊","FLUTAFIN CAPSULE 200MG (ACEFYLOYSTEINE)","衛署藥製字第030873號","ACETYLCYSTEINE","200mg","西德有機化學藥品股份有限公司","PICs/GMP查廠未通過，暫不准出貨","有同成份替代藥品使用，暫無醫療上問題。","生產廠商：美亞"
"54","2013.04","可舒鬆注射液20公絲","Copaxone 20mg Solution for Injection","衛署罕藥輸字第000015號","GLATIRAMER ACETATE","20MG","海喬國際股份有限公司","廠商供貨不足","經評估後建議使用同適應症替代藥品：(1)Fingolimod；(2)Natalizumab","有不同成份替代藥品使用，暫無醫療上問題。(無法購得者可申請專案進口)"
"58","2013.05.07","優樂黴素膠囊（紅絲菌素丙酯月桂硫酸醯）","ULOSINA CAPSULES (ERYTHROMYCIN ESTOLATE)","衛署藥製字第029697號","ERYTHROMYCI","250MG","優良化學製藥股份有限公司","停產","建議使用ERYTHROMYCIN (STEARATE)或ERYTHROMYCIN (ESTOLATE)","生產廠商：景德、利達、溫士頓、榮民、羅得、永信、健康"
"59","2013.05.07","優樂黴素口服懸濁液用顆粒（紅絲菌素丙酯月桂硫酸醯）","ULOSINA FOR ORAL SUSPENSION (ERYTHROMYCIN ESTOLATE)","衛署藥製字第029701號","ERYTHROMYCI","","優良化學製藥股份有限公司","停產","建議使用ERYTHROMYCIN (STEARATE)顆粒劑型","有不同成份替代藥品使用，暫無醫療上問題(元宙)。"
"60","2013.05.10","西力欣注射劑","ZINACEF FOR INJECTION","衛署藥製字第032357號","CEFUROXIME (SODIUM)","25mg/ml;50ml/Bot","荷商葛蘭素史克藥廠股份有限公司台灣分公司","停產","有同成份替代藥品使用，暫無醫療上問題。","有同成分，不同劑型、劑量藥品許可證共 > 20 張。生產廠商: 優良、景德、信東、中國化學等"
"62","2013.05.29","水合三氯乙醛","Chloral hydrate","內衛藥輸字第004918號 內衛藥輸字第000493號 衛署藥輸字第013503號","Chloral hydrate","","雄恆行股份有限公司 金源貿易股份有限公司","停產","7月公開徵求有意願之供應廠商,8月由吉帝跟醫院聯絡","有不同成份替代藥品使用，暫無醫療問題。"
"64","2013.06.25","脂黴素微脂粒凍晶乾粉注射劑","Ambisome for Injection","衛署藥輸字第023388號","AMPHOTERICIN B","50MG","禾利行股份有限公司","因藥品有汙染疑慮，廠商預防性全數回收","有同成份替代藥品使用，暫無醫療上問題。","生產廠商：微脂體，藥證於六月底通過，已於7/18取得健保價可供貨"
"66","2013.07.03","清華放射性碘－１３１膠囊","SODIUM IODIDE I-131 CAPSULES","衛署藥製字第R00008號","SODIUM IODIDE, SODIUM PHOSPHATE DIBASIC (ANHYDROUS)","","國立清華大學原子科學研究所同位素組","停產","有同成份替代藥品使用，暫無醫療上問題。","生產廠商：新吉美碩"
"67","2013.07.03","清華 放射性碘－１３１口服液","SODIUM IODIDE I-131 SOLUTION","衛署藥製字第R00003號","TELLURIC ACID, SPECIFIC RADIOACTIVITY","","國立清華大學原子科學研究所同位素組","停產","有同成份替代藥品使用，暫無醫療上問題。","生產廠商：行政院原委會核研所"
"68","2013.07.03","清華 放射性磷－３２注射液","SODIUM PHOSPHATE P-32 INJECTION","衛署藥製字第R00005號","SULFUR, SPECIFIC RADIOACTIVITY","","國立清華大學原子科學研究所同位素組","停產","有不同成份替代藥品使用，暫無醫療上問題。(此通報品項於國內未被使用，若是紅血球增多症之檢查還是使用Cr-51)","生產廠商：元新"
"69","2013.07.03","清華 碘-131標誌玫瑰螢紅注射液","SODIUM ROSE BENGAL I-131 INJECTION","衛署藥製字第R00002號","ROSE BENGAL SODIUM, SPECIFIC RADIOACTIVITY","","國立清華大學原子科學研究所同位素組","停產","有替代療法使用，暫無醫療上問題。","有其他輔助療法(本品主要作為肝膽功能輔助診斷使用，目前除了核醫的肝膽攝影外，另有超音波、CT、MRI等影像學方法可協助相關肝膽功能疾患診斷)"
"70","2013.07.03","碘１３１碘化油肝癌注射劑","I-131-LIPIODOL MALIGNANT HEPATOMA INJECTION","衛署藥製字第R00009號","-","","國立清華大學原子科學研究所同位素組","停產","建議使用其他療法治療如全身性化療、質子放射線療法、冷凍療法、經皮局部注射法(PET)、經導管動脈化學栓塞治療(TACE/TAE)","有不同成分替代藥品使用，暫無醫療上問題。"
"71","2013.07.03","清華 放射性鉻－５１注射液","SODIUM CHROMATE CR-51 INJECTION","衛署藥製字第R00001號","SPECIFIC RADIOACTIVITY, POTASSIUM CHROMATE","","國立清華大學原子科學研究所同位素組","停產","建議使用Cr-51(元新)","有不同成份替代藥品使用，暫無醫療上問題。"
"72","2013.07.03","清華 碘－１３１標誌馬尿酸注射液","SODIUM IODOHIPPURATE I-131 INJECTION","衛署藥製字第R00004號","2-IODOHIPPURIC ACID, SPECIFIC RADIOACTIVITY","","國立清華大學原子科學研究所同位素組","停產","建議使用betiatide(行政院原委會核研所)","有不同成份替代藥品使用，暫無醫療上問題。"
"74","2013.07.24","底偶素腸溶錠","STILBESTOL ECT","衛署藥製字第027978號","DIETHYLSTILBESTROL","1 MG","尼斯可股份有限公司新莊廠","廠房申請PIC/S，不再供應","經評估後建議使用替代藥品：(1)Androcur(2)Casodex(3)Fugerel(4)leuprolide 品名：(1)Cyproterone(臺灣拜耳) (2)Bicalutamide(臺灣阿斯特捷利康) (3)Flutamide(先靈葆雅)(4)leuprolide(臺灣武田、南光化學)","有不同成份替代藥品使用，暫無醫療上問題。"
"110","2013.12.06","采福適膜衣錠","ZYVOX TABLETS 600MG","衛署藥輸字第023181號","LINEZOLID","600mg / Tablet","輝瑞大藥廠股份有限公司","國外製造廠供貨不及(因為國外轉廠)","已恢復供貨","供應廠商：輝瑞"
"112","2013.12.13","信可得關節注射液","SHINCORT INJECTION ＂YUNG SHIN＂","衛署藥製字第011476號","TRIAMCINOLONE ACETONIDE","50mg/5cc/vial","永信藥品工業股份有限公司","廠商停產","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","供應廠商：壽元、台裕化學"
"113","2013.12.13","密鈣息注射液５０國際單位？公撮","MIACALCIC INJECTION 50 MRC-U/ML (50IU /ML)","衛署藥輸字第016704號","CALCITONIN SALMON","50IU /ML","臺灣諾華股份有限公司","廠商缺貨","已恢復供貨","供應廠商：諾華、瑞安"
"153","20140505","比視朗眼藥膏","Pzulen eye ointment","衛署藥製字第008645號","PREDNISOLONE, AZULENE","點眼膏劑","綠洲化學工業有限公司","與PIC/S相關","可以黴露霜眼藥水(五福)、點必舒眼用懸浮劑(愛爾康)等藥品取代。",""
"75","2013.07.25","精製結核菌素 RT23SSI","TUBERCULIN PPD RT23 SSI","衛署菌疫輸字第000736號","TUBERCULIN","","國光生物科技股份有限公司","國外製程問題造成短缺","建議缺藥期間改採用血液檢測方式，若要篩檢結核病高風險族群，建議轉介至公費醫療機關檢驗(國內尚有七千隻公費藥品)","有其他因應措施"
"76","2013.08.08","鹽酸四環素眼藥膏１％","TETRACYCLINE HCL OPHTHALMIC OINTMENT 1% ＂KINGDOM＂","內衛藥製字第016430號","TETRACYCLINE (HCL)","","景德製藥股份有限公司","廠商表示於2014年1月方可恢復供藥","有同成份替代藥品使用，暫無醫療上問題。","1.綠洲化學工業有限公司(售價高於健保核價) 2.溫士頓醫藥股份有限公司(102年9月供貨，由妙仁經銷) 3.人人化學製藥股份有限公司(停產中)"
"77","2013.08.08","速復滴劑","SOFRADEX DROPS","衛署藥輸字第021518號","FRAMYCETIN (SULFATE) SOFRAMYCIN(SULFATE), DEXAMETHASONE SODIUM SULFOBENZOATE M-, GRAMICIDIN","","賽諾菲股份有限公司","廠商表示於2014年1月方可恢復供藥","經評估後建議使用不同成分替代藥品：(1) MYCOMB OTIC DROPS ＂SINPHAR＂ (杏輝) (2) CILODEX STERILE OTIC SUSPENSION(愛爾康)","有不同成份替代藥品使用，暫無醫療上問題。"
"78","2013.08.15","羅飛龍－A注射劑","ROFERON-A ( SOLUTION FOR INJECTION )","衛署菌疫輸字第000700號","INTERFERON ALPHA- 2A","3、4.5、6MIU","羅氏大藥廠股份有限公司","許可證因為製造廠移轉,暫時無法供應藥品","經評估後建議使用替代藥品：INTERFERON ALPHA","有不同成份替代藥品使用，暫無醫療上問題 (默沙東INTRON A MULTIDOSE PEN 、羅氏 PEGASYS PREFILLED SYRINGES)"
"79","2013.09.02","鉈－２０１氯化亞鉈注射液","THALLIUM CHLORIDE-T1 201 INJECTION","衛署藥輸字第R00030號","THALLIUM TL-201","注射劑","元新儀器有限公司","藥物許可證到期，無法再行供應","有同成份替代藥品使用，暫無醫療上問題。","元新進口之產品因濃度規格變動(原為1 mCi/ml變更為2mCi/ml，舊有規格不再生產)，新藥證申請書擬於九月送出申請。另國內尚有兩家持續供應之廠商，可供應同成分不同濃度之藥品: (1)原能會(1.6 mCi/ml)(衛署藥製R00012)，惟7月因儀器故障暫停生產，於9/5後可恢復供應。(2)新吉美碩(2 mCi/ml)(衛署藥輸R00077)，目前供貨穩定。臨床上本藥品之使用，是以靜脈輸入病人體內的總輸入劑量為考量點，非以藥品的濃度為考量點。因此，臨床上不同濃度的藥品，皆可以互相替代使用。"
"80","2013.09.03","鎵－６７檸檬酸鎵注射液","GALLIUM CITRATE-GA 67 INJECTION","衛署藥輸字第R00009號","SODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE ISOTONIC INJECTABLE SOLUTION, GALLIUM GA-67, BENZYL ALCOHOL, SODIUM HYDROXIDE","注射劑","元新儀器有限公司","藥物許可證到期，無法再行供應","經評估後，有兩間廠商可供應此藥物，而單位濃度劑量(2mCi/ml)是元新儀器成品(1mCi/ml)的2倍。","原元新儀器公司代理之Gallium Citrate-GA 67 Injection因藥品許可證到期(效期: 102/08/10)無法供貨。102年8月起開始由臺灣新吉美碩公司提供Ga-67至各大醫院。102年9月現況：(1)核能所加速器已修復，已可正常製造供貨。聯絡單位：核能所藥產中心，電話：03-4711400轉7158 (2)臺灣新吉美碩公司Ga-67供應量充足。"
"81","2013.09.05","西德有機新黴素膠囊250毫克","NEOMYCIN CAPSULES 250mg ＂SHITEH＂","內衛藥製字第005396號","NEOMYCIN (SULFATE)","膠囊劑","西德有機化學藥品股份有限公司","因代工廠轉證程序尚未完成，造成無法正常供貨，預計2013/12/31可恢復供貨。","有同成份替代藥品使用，暫無醫療上問題。(102/12/4經研究助理電聯後，西德藥廠表示預計103/2月開始供貨)","建議可先採用順華公司藥品(藥名：紐奧黴素膠囊250公絲，藥製字第011518號，健保代碼：A011518100)。西德有機表示因轉證時間比預估要長，導致原料藥供應不足，預計年底才能供貨，但若供貨正常後會即刻通知。另經詢問順華藥品公司後，該公司表示貨源供應正常。"
"82","2013.09.05","杏輝 金貝比嬰兒擦劑","SINBABY BABY LOTION ＂SINPHAR＂","衛署藥製字第020215號","DIPHENHYDRAMINE, DIBUCAINE HCL, ZINC OXIDE","洗劑","杏輝藥品工業股份有限公司","廠商缺貨","經評估後，建議可根據其主成分zinc oxide, diphenhydramine, dibucaine hydrochloride, dl-camphor,及 benzalkonium個別開立處方。另也可考慮使用派頓＂膚喜軟膏作為替代用藥，唯派頓＂膚喜軟膏的主成分並未包括benzalkonium。","有不同成份替代藥品使用，暫無醫療上問題。"
"83","2013.09.11","速溶 泛艾黴素１０公絲","PHARMORUBICIN RAPID DISSOLUTION 10MG","衛署藥輸字第019120號","EPIRUBICIN HCL","凍晶注射劑","輝瑞大藥廠股份有限公司","廠商缺貨","有同成份替代藥品使用，暫無醫療上問題。(經評估後，台灣東洋公司曾於國內進行Epirubicin之臨床試驗，療效與安全性評估皆符合要求。部分醫學中心已採購引進使用，應可列為優先徵詢供應之對象。)","目前國內尚有台灣東洋及聯邦化學製藥公司生產10mg/vial規格，海喬代理Epirubicin-Teva效期短(效期至102年11-12月)且數量不多。另有多家藥廠生產50mg/vial規格製劑，可供臨床使用。"
"84","2013.09.12","優力黴素口服懸液用顆粒（賜福力欣）","ULEXIN FOR ORAL SUSPENSION (CEPHALEXIN)","衛署藥製字第017280號","CEPHALEXIN (MONOHYDRATE)","懸液用顆粒劑","優良化學製藥股份有限公司","廠商年底供貨","有同成份替代藥品使用，暫無醫療上問題。","經評估後，可用其他劑型取代，或是依感染部位或是菌種採用其他抗生素口服液劑 (如augmentin)。有同成分，不同劑型、劑量藥品許可證共 12 張。 供應廠商: 永信、元宙化學、台裕化學等"
"89","2013.10.23","吉普寧糖衣錠","TIOPRONIN S.C. TABLETS ＂S.T.＂","衛署藥製字第018926號","TIOPRONIN","糖衣錠","信東生技股份有限公司","國內無人生產，亦無代理商進口。","經評估後建議使用替代藥品：Penicillamine(禾利行)","有不同成份替代藥品使用，暫無醫療上問題。"
"96","2013.11.07","疏痙 直腸用液劑１０公絲","STESOLID RECTAL TUBE 10MG","衛署藥輸字第023460號","DIAZEPAM","10MG","臺灣美強股份有限公司","因產地變更未辦理導致缺藥","經評估後，各醫院若有醫療需求可以專案進口方式提出申請","有廠商協助專案進口，暫無醫療上問題(供應者:美強)"
"106","2013.12.03","好度得注射液","HALDOL DECANOAS","衛署藥輸字第019475號","HALOPERIDOL (DECANOATE)","50MG/ML","嬌生股份有限公司","製造廠產能問題，2014年中以前可能有供貨短缺之問題","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","供應廠商：瑞士"
"85","2013.10.04","必先優注射劑","BICNU (CARMUSTINE (BCNU)) 100MG","衛署藥輸字第006292號","CARMUSTINE","100 mg/vial","臺灣必治妥施貴寶股份有限公司","國外經銷權轉移","經評估後，本品為專案進口藥品且因國外許可證賣給【Emcure Phar.Limited】再授權Idis為台灣獨家代理，故建議改向Idis代理聯繫","因無許可證目前已請吉帝公司協助與Idis聯絡"
"86","2013.10.08","人人紫菌素眼用軟膏３公絲/公克","GENTAMYCIN OPHTH. OINTMENT 3MG/GM ＂GCPC＂","衛署藥製字第025128號","GENTAMICIN (AS SULFATE)","3MG/GM","人人化學製藥股份有限公司","廠商皆缺藥","有同成份替代藥品使用，暫無醫療上問題。","瑞士商愛爾康大藥廠股份有限公司的愛康明眼藥膏貨源充足，可提供各醫療院所使用。"
"87","2013.10.16","台裕安西諾隆注射液１０公絲","TRIAMCINOLONE SUSPENDED INJECTION 10MG ＂TAI YU＂","衛署藥製字第013578號","TRIAMCINOLONE ACETONIDE","10mg/ml","臺裕化學製藥廠股份有限公司","因生產工廠逢PIC/S查廠, 以致目前無法正常供貨","有同成份替代藥品使用，暫無醫療上問題。","經電詢，國內廠目前仍有壽元(10mg/ml,藥製字第012527號；40mg/ml,第016963號)、汎生(40mg/ml, 藥製字第020668號)，以及大豐製藥(40mg/ml, 藥製字第033773號)仍有持續生產相同劑型成分注射劑。"
"88","2013.10.23","塞克羅邁得糖衣錠５０公絲","SYKLOFOSFAMID S.C. TABLETS 50MG","衛署藥輸字第016754號","CYCLOPHOSPHAMIDE","50MG/tab","臺灣美強股份有限公司","廠商不再進貨","有同成份替代藥品使用，暫無醫療上問題。","生產廠商：百特，但因百特庫存不足無法供貨給全數醫院，目前已有許多醫院斷藥，暫時以針劑取代，已公告徵求廠商供應口服劑型，已有廠商協助詢問國外製造廠 (10/23更新)電聯裕利公司[02-25776438]後表示，cyclophosphamide口服與注射劑型現況供應正常。"
"90","2013.10.28","治疣液","DUOFILM","衛署藥輸字第017603號","COLLODION, SALICYLIC ACID, LACTIC ACID","外用液劑","荷商葛蘭素史克藥廠股份有限公司台灣分公司","國外生產線整合，預計103年度第四季恢復供貨","有不同成份可替代藥，12月起原短缺廠商已可正常供貨","已恢復供貨(廠商通報於12月起可正常供貨)"
"91","2013.10.29","景德 可利明眼藥膏1%(氯絲菌素)","CHLORLYMIN OPHTHALMIC OINTMENT 1% ＂KINGDOM＂ (CHLORAMPHENICOL)","衛署藥製字第046069號","CHLORAMPHENICOL","眼用軟膏劑","景德製藥股份有限公司","停產(PIC/S改建)","有同成份替代藥品使用，暫無醫療上問題。","供應廠商：綠洲化學工業有限公司"
"92","2013.10.29","利福全錠２毫克（可那氮平）","RIVOTRIL TABLETS 2MG (CLONAZEPAM)","衛署藥製字第036175號","CLONAZEPAM","2MG","羅氏大藥廠股份有限公司","民眾通報廠商無原因不供貨","有同成份替代藥品使用，暫無醫療上問題。","供應廠商：羅氏、十全、應元三家藥廠貨源充足，可供應各醫療院所，包括藥局。"
"93","2013.11.06","“管制藥品廠”吩坦尼穿皮貼片劑 25 微公克/小時","Fentanyl Transdermal Patch 25 μg/hr“PPCD”","衛署藥製字第050018號","FENTANYL (EQ TO FENTANYL BASE)","","衛生福利部食品藥物管理署管制藥品製藥工廠","因行政作業流程因素造成供應量不穩定","預計102年11月11日起恢復全面供貨","已恢復供貨"
"94","2013.11.06","氯黴素琥珀酸酯鈉鹽注射劑１克","INCHLOMYCIN SODIUM SUCCINATE INJECTION 1GM ＂C.Y.＂","衛署藥製字第006932號","CHLORAMPHENICOL (SODIUM SUCCINATE)","1 MG","聯邦化學製藥股份有限公司","配合衛生署執行PIC/S GMP，故停止生產","經評估後，建議使用不同成分可替代藥品：(1)fluoroquinolones (2)cephalosporins","有不同成份替代藥品使用，暫無醫療上問題。"
"95","2013.11.07","敏克瘤注射液１公絲？公撮","VINCRISTINE-TEVA SOLUTION 1MG/ML","衛署藥輸字第022167號","VINCRISTINE SULFATE","1mg/ml/Vial","海喬國際股份有限公司","國外原廠無法如期出貨致缺貨","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","供應代理商：大用股份有限公司"
"97","2013.11.12","綠洲 氯黴素眼藥膏","CHLORAMPHENICOL OPHTHALMIC OINTMENT","衛署藥製字第004490號","CHLORAMPHENICOL","","綠洲化學工業有限公司","廠商產量不足","有同成分、不同劑型、同劑量藥品使用，暫無醫療問題","供應廠商：建議以CHLORAMPHENICOL 0.25% EYE DROPS眼藥水替代 1.杏輝藥廠或 2.應元藥廠"
"98","2013.11.13","安米諾靜脈輸注液５％Ｗ？Ｖ","AMINOSTERIL 5% W/V FOR I.V. INFUSION","衛署藥輸字第020237號","L-ALANINE, L-ARGININE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE ACETATE, L-METHIONINE, ORNITHINE L- ASPARTATE L-, L-PHENYLALANINE, L-PROLINE, L-SERINE, L-THREONINE, L-TRYPTOPHAN, N-ACETYL TYROSINE L-, L-VALINE, GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL), TAURINE (EQ TO 2-AMINOETHANE SULFONIC ACID)","","臺灣費森尤斯卡比股份有限公司","原廠已經不再生產","經評估後，建議使用不同成分可替代藥品：(1)Aminoven 5% (2)Aminoplasmal-5% E (臺灣費森尤斯卡比股份有限公司、臺灣柏朗股份有限公司)","有不同成份替代藥品使用，暫無醫療上問題。"
"155","20140210","＂景德＂ 紅黴素眼藥膏 0.5%","Erythromycin oph oint 0.5% 3.5 g","衛署藥製字第047370號","ERYTHROMYCIN BASE","5.0 MG","景德製藥股份有限公司","PIC/S轉換","已恢復供貨",""
"156","20140210","＂景德＂ 可利明眼藥膏1%(氯絲菌素)","CHLORLYMIN OPHTHALMIC OINTMENT 1% ＂KINGDOM＂","衛署藥製字第046069號","CHLORAMPHENICOL","10.0MG","景德製藥股份有限公司","PIC/S轉換","已恢復供貨",""
"157","20140212","促甲狀腺激素釋放荷爾蒙注射液〝田邊〞","TRH inj","衛署藥輸字第016336號","PROTIRELIN(TRHTRF)","0.5 MG/ML","臺田藥品股份有限公司","藥品許可證逾期不展延。","專案進口; 廠商預計2018年國外廠符合PIC/S",""
"158","20140212","黃體形成荷爾蒙分泌荷爾蒙注射液","LH-RH inj","衛署藥輸字第017275號","GONADORELIN ACETATE","0.1 MG /ML","臺田藥品股份有限公司","藥品許可證逾期不展延。","專案進口; 廠商預計2018年國外廠符合PIC/S",""
"99","2013.11.14","Ｂ型肝炎免疫人血球蛋白注射液","HEPATITIS B IMMUNE GLOBULIN (HUMAN), HYPERHEP B S/D","衛署菌疫輸字第000452號","HEPATITIS B IMMUNOGLOBULIN","","天行貿易股份有限公司","該公司訂貨人員表示藥品已在藥檢署封緘中","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","經評估後，有同成分、同劑型、同劑量藥品許可證共2張 ，持續供應共2張。並建議，暫以0.5ml/pc或1ml/pc包裝替代使用。供應廠商：天行貿易股份有限公司、吉發企業股份有限公司"
"100","2013.11.14","密鈣息鼻噴霧劑１００國際單位","MIACALCIC NASAL SPRAY 100I.U.","衛署藥輸字第018161號","CALCITONIN SALMON","","臺灣諾華股份有限公司","廠商無法供應此藥","有同成分，不同劑型、劑量藥品許可證使用，暫無醫療問題。","根據衛生福利部食品藥物管理署於10月1日之公告，因Calcitonin長期使用可能有增加 癌症的風險，Calcitonin之鼻噴劑與注射劑型已不建議用於治療骨質疏鬆症。"
"101","2013.11.19","醫百幸注射劑20公絲/公撮","EPOSIN CONCENTRATE FOR INFUSION SOLUTION 20MG/ML","衛署藥輸字第023436號","ETOPOSIDE","100 mg/5 mL/vial","民橋企業股份有限公司","廠商缺藥","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","供應廠商：海喬、台灣費森尤斯卡比"
"102","2013.11.19","米諾信乾粉注射劑100毫克(美諾四環素)","MIROSIN 100MG FOR INJECTION (MINOCYCLINE) ＂PANBIOTIC＂","衛署藥製字第034352號","MINOCYCLINE (HCL)","10VIAL","臺灣汎生製藥廠股份有限公司","為符合PIC/S規定，廠區及生產線配合整修中，故無法製造","有同成分，不同劑型、劑量藥品許可證使用，暫無醫療問題。","供應廠商：永信、瑞安"
"103","2013.11.20","硫酸奎尼丁膠囊","QUINIDINE SULFATE CAPSULES ＂NYSCO＂","內衛藥製字第000990號","QUINIDINE SULFATE","","尼斯可股份有限公司新莊廠","廠商來函通知缺貨","經評估後，廠商預定102.12.13可供應。如如暫無藥品可用，建議使用不同成分可替代藥品： (1)Cordarone/amidarone (2)Tambocor/ Flecainide acetate (3)Rytmonorm /Propafenone","有不同成份替代藥品使用，暫無醫療上問題(Sanofi-winthrop、3M health care、Abbott)"
"104","2013.11.22","寧黴素５００公絲靜脈注射劑","RIFOCIN INTRAVENOUS 500MG","衛署藥輸字第021956號","RIFAMYCIN SV (SODIUM)","500mg/amp","賽諾菲股份有限公司","廠商停止進口藥品","經評估後，單一進口商表示已無存貨，未來亦不再進口，已徵得有意願供應之藥商","有廠商協助專案進口"
"105","2013.11.25","泛可黴素靜脈注射劑500公絲","VANCOMYCIN HYDROCHLORIDE FOR INJECTION 500MG ,USP","衛署藥輸字第017742號","VANCOMYCIN (HCL)","","新加坡商赫士睿股份有限公司台灣分公司","經銷商說國外廠缺原料","有同成分、同劑型、同劑量藥品使用，暫無醫療問題","供應廠商：政德製藥、諾華"
"108","2013.12.04","樂拿舒注射劑５０００ＫＵ","LEUNASE INJECTION (5,000 K.U.)","衛署藥輸字第021036號","L-ASPARAGINASE","","台灣協和醱酵麒麟股份有限公司","廠商缺藥","目前國內有專案進口Erwinia L-asparaginase 10,000 Units/vial","供應廠商：EUSA PHARMA"
"109","2013.12.06","艾斯美特 延釋膠囊90毫克","ACEMET RETARD CAPSULES 90MG","衛署藥製字第046072號","ACEMETACIN","90 mg/cap","健喬信元醫藥生技股份有限公司","TFDA公告須重作BA/BE品項,以致廠商不可交貨","有同成分，不同劑型、劑量藥品，暫無醫療問題","供應廠商：健喬信元(60 mg，藥製字第040011號)"
"111","2013.12.10","阿米若靜脈輸注液10％","AMINOSTERIL INFANT 10% W/V FOR INTRAVENOUS INFUSION","衛署藥輸字第022023號","L-ALANINE, L-ARGININE, L-HISTIDINE, ISOLEUCINE DL-, L-LEUCINE, L-LYSINE ACETATE, L-METHIONINE, L-PHENYLALANINE, L-PROLINE, L-SERINE, L-THREONINE, L-TRYPTOPHAN, N-ACETYL TYROSINE L-, L-VALINE, GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL), N-ACETYL-L-CYSTEINE, TAURINE (EQ TO 2-AMINOETHANE SULFONIC ACID), MALIC ACID L-","10% 100ml/BT","臺灣費森尤斯卡比股份有限公司","廠商庫存沒有貨了","已恢復供貨","若後續再發生此缺藥情形，可以南光產品取代(愛兒健注射液10% /Pedicare Injection 10%)"
"114","2013.12.16","壓得平錠５公絲（阿米諾樂）","EDEPIN TABLETS 5MG (AMILORIDE) ＂SWISS＂","衛署藥製字第040428號","AMILORIDE HCL, AMILORIDE HCL ANHYDROUS","5mg/tab","瑞士藥廠股份有限公司","廠商目前已不再生產","國內目前無Amiloride單方與Triamterene單方供Liddle syndrome病人使用，建議啟動缺藥處理機制公開招商。","有廠商協助專案進口"
"115","2013.12.17","欽納特懸液劑１２５公絲","ZINNAT SUSPENSION 125MG","衛署藥輸字第019420號","CEFUROXIME AXETIL","125 mg cefuroxime/5 mL, 50 mL/btl","荷商葛蘭素史克藥廠股份有限公司台灣分公司","廠商來文表示此產品將於民國103年停止進口","有同成分，不同劑型、劑量藥品，暫無醫療問題","供應廠商：生達、永信(建議因抗生素的使用因適應症不同，藥物的治療定位也不同；故各醫院可依臨床疾病選擇其他抗生素治療)"
"159","20140807","愛治膠囊５００公絲","HYDREA CAPSULES 500MG","衛署藥輸字第023135號","hydroxyurea","500 mg/cap","臺灣必治妥施貴寶股份有限公司","供需不平衡、供貨延遲","已恢復供貨",""
"160","20141126","脈律循膠囊１００公絲〝信東〞","MELETIN CAPSULES 100MG ＂S.T.＂ (MEXILETINE)","衛署藥製字第043632號","Mexiletine","100mg / Cap","信東生技股份有限公司","供需不平衡、供貨延遲","12/22廠商說明已穩定供貨",""
"161","20140326","〝台灣東洋〞克痢黴素注射劑200萬單位（可麗基美壽）","T.T.Y. COLIMYCIN INJECTION","衛署藥製字第024961號","COLISTIN METHANESULFONATE","2000000 U","臺灣東洋藥品工業股份有限公司","供需不平衡、供貨延遲","已穩定供貨",""
"116","2013.12.17","特泯菌靜脈注射劑","TIMENTIN INTRAVENOUS","衛署藥輸字第018882號","TICARCILLIN (DISODIUM), CLAVULANATE (POTASSIUM)","","荷商葛蘭素史克藥廠股份有限公司臺灣分公司","原廠停止進口","經評估後，改用其他extended-spectrum penicillin/ß-lactamase inhibitor組合，例如piperacillin/tazobactam，或依菌種感受性選擇其他合適的抗生素。","有不同成份替代藥品使用，暫無醫療上問題(Pfizer)。"
"117","2013.12.19","核研去氧葡萄糖〔氟－１８〕注射劑","INER FLUDEOXYGLUCOSE {F-18} INJECTION","衛署藥製字第R00018號","",">3 mCi/mLInjection","行政院原子能委員會核能研究所","","經評估後，國內有不同成分藥品可替代藥：由符合「斷層掃描用正子放射同位素調製作業要點」之醫院藥局調劑，供病人使用。","有不同成份替代藥品使用，暫無醫療上問題。"
"118","2013.12.25","泰吉利濃縮靜脈輸注液 300 毫克","Tysabri concentrate for solution for infusion 300mg","罕菌疫輸字第000014號","Natalizumab","","華宇藥品股份有限公司","廠藥品中文包裝生產未完成,須延至103.2月中旬才可進口","經評估後，國內無其它同成分或類似產品。雖然可替代藥品有β-interferon、glatiramer acetate，以及免疫抑制劑等可供醫療，然而這些替代藥品與原藥之作用機轉不同，且目前並無替換後是否能接續穩定病患情況之臨床研究可供參考。故對於已經使用本品並治療穩定之患者，不建議停藥或是換藥故將督促原廠中文包裝儘速更換進行。",""
"119","20140101","緩釋鉀糖衣錠","slow-K tab 600 mg","衛署藥輸字第010085號","potassium chloride","600 mg","臺灣諾華股份有限公司","原廠已經不再生產","市面上有仍有鉀離子補充劑，衛署藥製字第022314號，暫無醫療上問題。","建議使用POTASSIUM GLUCONATE，生產廠商：寶齡富錦"
"120","20140102","可致律錠","Clozaril tab 25 mg","衛署藥輸字第018541號","Clozapine","25 mg","臺灣諾華股份有限公司","而產地變更至新廠Kurtkoy/Turkey乙案目前仍在食品藥物管理局辦理當中 (案號：1015054172)，故擬暫時無法供應新廠藥品至國內。","同成分、同劑型、同劑量有許可證且持續供應有2家 (瑞士、汎生)。同成分，不同劑型、劑量有5家 (諾華、瑞士、汎生、信東、優生)","有同成份、不同成份替代藥品使用，暫無醫療上問題。"
"121","20140108, 20140423","葡萄糖酸鈣注射液10% ＂C.C.P.C.＂","葡萄糖酸鈣注射液10% ＂C.C.P.C.＂","","CALCIUM GLUCONATE INJECTION 10%","200 ml","","考量成本，已不再生產","以Calglon IV injection 10% 10 mL替代","有同成份、不同容量藥品使用，暫無醫療問題。"
"122","20140115","＂優良＂ 磷酸鉀注射液","Potassium phosphate injection","衛署藥製021343號","POTASSIUM PHOSPHATE (POSTASSIUM PHOSPHATE DIBASIC), POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE)","20 ml/amp","優良化學製藥股份有限公司","優良化學製藥因GMP證明廢止","健喬信元已於102年併購優良化學製藥產品與藥證，經電話詢問健喬信元表示，目前potassium phosphate inj.仍正常供貨，無缺貨之虞。","健喬信元委託大豐製造，藥名成維持原名"
"123","20140116","安達菌素乾粉注射劑","Azactam 1g/vial","衛署藥輸字第023105號","Aztreonam","1 g/vial","臺灣必治妥施貴寶股份有限公司","必治妥已停產。另一台廠台裕化學亦回應不生產。","以不同成份藥品替代。Ceftazidime，Tobramycin","依據Sanford guide (熱病)資料顯示，Azactam抗菌範圍主要以G(-)菌為主，尤其是對於Pseudomonas aeruginosa (綠膿桿菌)具有良好療效，因Ceftazidime抗菌範圍、支鏈結構與Azactam相似，建議可用Ceftazidime針劑作為療效取代品；若以吸入Azactam治療P. aeruginosa造成肺囊胞性纖維化(cystic fibrosis)等呼吸道症狀時，建議可用Tobramycin以吸入給藥作為取代。"
"124","20140122","＂速溶＂ 泛艾黴素１０公絲、５０公絲","Pharmorubicin rapid dissolution 10 mg and 50 mg","衛署藥輸字第019120號 ，衛署藥輸字第019119號","EPIRUBICIN HCL","10 mg, 50 mg","輝瑞大藥廠股份有限公司","原料藥供應短缺","建議可先以他廠同成份、同劑型、同劑量藥品替代","有同成份藥品，暫無醫療問題(東洋、聯邦化學、臺灣費森尤斯卡比)。"
"125","20140122","＂貝靈＂ 血清蛋白注射液２０％","Albumin Injection 20% 50 mL/btl (CENTEON)","衛署菌疫輸字第000491號","albumin","50 ml","吉發企業股份有限公司","吉發企業股份有限公司表示衛署菌疫輸字第000491號Albumin Injection 20% 50 mL/btl (CENTEON)之製造廠CSL Behring GmbH供貨不足,無法供應","建議以同成分、同劑型、同劑量藥品衛署菌疫輸字第000842號替代","可用Albuminar-20 (吉發), TBSF (20%) Human albumin (台灣血液基金會), Uman albumin20 %(輔凱)替代,但鑑於台大醫院所需量甚大，Albuminar-20 (吉發,要簽約), Uman albumin20 %(輔凱)無法供應，故建議用 TBSF (20%) Human albumin (台灣血液基金會)替代"
"126","20140212","鋅錠１５公絲","ZINC TABLETS 15MG ＂GCPC","衛署藥製字第025124號","ZINC (ZINC SULFATE)","15MG","人人化學製藥股份有限公司","停產","建議以zinc gluconate取代zinc sulfate，另外搭配ascorbic acid使用。","Zinc gluconate: 目前國內有6張許可證，4張正常生產供應 Zinc acetate dihydrate: 目前國內有4張許可證均正常供應"
"137","20140109 20140117","","Methotrexate (MTX) 1 g/40 ml","","Methotrexate","1 g/ 40 ml","赫士睿、諾華","因國外製廠產能因素,致缺貨","103年5月~7月間，有許可證廠商(赫士睿、諾華)已持續進口，無缺藥之虞","供貨廠商:赫士睿、諾華"
"140","20140605","紐普洛穿皮貼片劑 8 毫克/ 24 小時","Neupro Transdermal Patch 8mg/24h","衛署藥輸字第024936號","ROTIGOTINE","穿皮貼片劑","友華生技股份有限公司","代理權變更","已通知恢復供應",""
"142","20140623","＂永豐＂ 芻基青黴素鈉注射液用粉","PENICILLIN G SODIUM INJECTION ＂Y.F.＂","衛署藥製字第014756號","PENICILLIN G SODIUM","乾粉注射劑","永豐化學工業股份有限公司","健保停止給付","已於6/30恢復健保價",""
"127","20140220","","FLUOROURACIL INJECTION","","FLUOROURACIL","","","藥品前因供藥短缺,暫以專案進口供應,健保署對進口藥品暫予納入給付1年,因給付期即將屆滿,故需再確認","目前市場供貨充足，有需求的醫院可自行向南光化學製藥或新加坡商美納里尼醫藥(英維達)訂藥，不需申請專案進口。","專案進口給付期屆滿後應不需展延。"
"128","20140220","","leucovorin INJECTION","","FOLINATE CALCIUM (CALCIUM LEUCOVORIN)","","","藥品前因供藥短缺,暫以專案進口供應,健保署對進口藥品暫予納入給付1年,因給付期即將屆滿,故需再確認","目前市場供貨充足，有需求醫院可自行向各供貨廠商訂藥，不需申請專案進口。","專案進口給付期屆滿後應不需展延。"
"129","20140324","溶栓　凍晶注射劑２５萬單位","Streptase","衛署藥輸字第021926號","Streptokinase","250000IU inj","吉發企業股份有限公司","停產或停止進口","streptokinase FDA labeled indications:AMI,DVT,PE,AT and Arteriovenous cannulation.可以使用替代藥品tenecteplase,Alteplase但價錢較昂貴，且有健保給付規範較受於限制；用於血液透析及通人工血管時可以urokinase或Heparin替代。","1.此藥物國內外皆已停產 2.此藥屬於外來蛋白質具抗原性會發生皮疹發燒及過敏"
"130","20140403","必醫你舒５ＫＥ注射劑","PICIBANIL 5KE","衛署藥輸字第019924號","PENICILLIN G POTASSIUM (BENZYLPENICILLIN POTASSIUM ), STREPTOCOCCUS PYROGENE SU STRAIN TX WITH PN G POTASSIUM","凍晶乾燥注射劑","臺灣中外製藥股份有限公司","供需不平衡、供貨延遲","國內目前登記Streptococcus pyogenes之藥品許可證，只有中外製藥一張由於目前供需不平衡及供貨延遲，故可能造成藥物短缺為免於醫療中斷，建議以替代藥物minocycline50mg/cap或tetracycline250mg/cap治療","本品之衛生署核准適應症包括：消化器癌、頭頸部癌、甲狀腺癌及肺癌。本品之健保給付規範為「限惡性腫瘤患者患有惡性腹水，肋膜積水或心包膜積水時使用，需檢附病歷摘要。」惡性腫瘤轉移後導致的各類積水情況，仍以外科介入引流為最主要的處理方式。處置肋膜積水後，考慮施行肋膜沾黏術(pleurodesis)並給予藥品避免肋膜再度積水。可使用藥品包括tetracycline, minocycline, talc...etc(但該類藥品用於肋膜沾黏數仍屬off-label use)"
"131","20140415","脂倍坦膠囊","Olbetam","衛署藥輸字第017140號","Acipimox","250mg/Capsule","輝瑞大藥廠(股)公司","供需不平衡、供貨延遲","可用Cholexamin Tables200 mg/tab(杏林)、Nidadd Sustained Release Tablets 500 mg/tab(世育)、Perycit Tablets 250 mg/tab(扶陞)替代(7/22與廠商聯絡，廠商回覆已正常供貨)","由於Olbetam國內目前沒有其他競爭的學名藥，因此建議以同類藥取代。此外，亦可考慮啟動缺藥處理機制，暫時核准於台灣無許可證之藥品Yiping或Nedios，因該2項藥品組成成分與Olbetam相同。"
"132","20140421","利保維源注射劑","lyo-povigent","衛署藥字第039392號","PANTHENOL D-(EQ TO D-PANTHENOL), VITAMIN A PALMITATE, BIOTIN, NIACINAMIDE (NICOTINAMIDE), THIAMINE HYDROCHLORIDE, RIBOFLAVIN PHOSPHATE SODIUM, PYRIDOXINE HCL, CYANOCOBALAMIN (VIT B12), FOLIC ACID, ASCORBIC ACID (VIT C), CHOLECALCIFEROL ( EQ TO VIT D3) ( EQ TO VITAMIN D3), TOCOPHEROL (ACETATE ALPHA DL- ), PHYTOMENADIONE(VIT K1)","凍晶注射劑","中國化學製藥股份有限公司","生產線整合及安排","請視醫院存量調整臨床處方劑量至供貨正常，若有可使用三合一製劑的病人可視情況調整處方","Lyo-povigent (中化) 103/7 可恢復供貨"
"133","20140428","“華興”速可淨高氟牙齒塗佈凝膠","SCODYL DENTAL GEL“H.S.”","衛署藥製044337號","SODIUM MONOFLUOROPHOSPHATE, SODIUM FLUORIDE","牙科用凝膠劑","華興化學製藥廠股份有限公司","藥證到期、查驗登記未過或代理權變更","改以黃氏製藥股份有限公司生產的Standard-Fluor Dental Gel (史丹氟雙氟牙齒塗佈凝膠)(衛署藥製字第048702號)替代","臨床使用可改以同成分、劑型、劑量之Standard-Fluor Dental Gel替代，但本品規格較小，每支為20gm(Scodyl dental gel為300gm/tube)，且無健保價，須自費購買。"
"134","20140509","＂瑞安＂ 福滿內服液劑","FUMIDE OREAL SOLUTION 10MG/ML ＂PURZER＂","衛署藥製字第044046號","furosemide","10 mg/mL, 120 mL/btl","瑞安大藥廠股份有限公司","機器故障暫無法生產","依病患使用需求條件容許下改以口服錠劑或注射方式為之。","單純為製造廠商原料供應不及，非全球短缺現象。"
"135","20140605","可體灌腸液１．６６７公絲？公撮（皮質醇）","CORTEMA ENEMA 1.667MG/ML ＂PURZER＂","衛署藥製字第038075號","HYDROCORTISONE","外用液劑","瑞安大藥廠股份有限公司","生產線整合及安排","可考慮以口服或注射方式給予Hydrocortisone，Prednisolone或Dexamethasone，或使用含有Mesalazine成分之浣腸劑型或口服藥品。上述方式皆無法改善病患病況時，可考慮注射Humira (Adalimumab)。","已恢復供應"
"136","20140102 20140109","米諾信乾粉注射劑100毫克(美諾四環素)","Mirosin 100 mg for imjection ＂Panbiotic＂","衛署藥製字第034352號","minocycline","100 mg乾粉注射","臺灣汎生製藥廠股份有限公司","TFDA公告下架回收，國內已無藥廠生產","以同成份口服劑型及不同成份替代藥品 (依細菌敏感測試)使用","建議優先以同成分、口服劑型作為取代，根據Johns Hopkins ABX Guide中資料顯示，藥品吸收率約為90%；如需使用針劑治療，建議依病人臨床上細菌敏感性測試結果選用適當藥品。若作為肋膜沾黏術(pleurodesis)的硬化劑使用，則可用picibanil(OK-432)、bleomycin或mitomycin C等化療藥品取代，或改用胸腔外科之機械性肋膜沾黏法(mechanical pleurodesis)。"
"143","20140219","","Proglycem/Diazoxide","無許可證","","","香港商艾維斯股份有限公司","因原廠將更換代理商，原代理商艾維斯已不再供貨，目前亦無庫存。","已找到可供應之廠商",""
"151","20131029","景德 欣舒敏眼藥膏","Cindecason Ophthalmic Ointment ＂Kingdom＂","衛署藥製字第047717號","NEOMYCIN SULFATE, DEXAMETHASONE SODIUM PHOSPHATE","點眼膏劑","景德製藥股份有限公司","停產(PIC/S改建)","已恢復供貨",""
"138","20140221 20140306","白蛋白注射劑","Plasbumin-25","衛署菌疫輸字第000197號","ALBUMIN HUMAN","12.5g/50mL/vial","天行貿易股份有限公司","因國際貨源短缺，無法供貨。","可用TBSF (20%) Human albumin (台灣血液基金會)、Albiomin 20%(禾利行)替代","有同成分、同劑型、同劑量藥品許可證共3 張，持續供應共 0 張。有同成分，不同劑型、劑量藥品許可證共11張，持續供應共7張"
"139","20140528, 20140630","第九凝血因子複合注射劑","Beriplex P/N","衛署菌疫輸字第000520號","Protein C, FACTOR II, FACTOR VII, FACTOR IX, FACTOR X, Protein S Antigen","凍晶乾燥注射劑","吉發企業股份有限公司","該公司考量藥品成本高出健保給付價格，公司無法負荷成本，故已停止該藥品進口。","一般多使用在血友病患者發生抗體治療使用，臨床上可以Feiba及Novoseven替代使用。Beriplex N/P 少數情況下使用於類血友病(von Willebrand disease)治療，此類血友病目前臨床上亦可以Haemate P和Alphanate治療。","Beriplex N/P 凝血因子複合注射劑，含第二、第七、第九、第十凝血因子，一般多使用在血友病患者發生抗體治療使用，藥品短缺時，臨床上可以Feiba及Novoseven替代使用。Beriplex N/P 少數情況下使用於類血友病(von Willebrand disease)治療，此類血友病目前臨床上亦可以Haemate P和Alphanate治療。經瞭解替代藥品製劑目前貨源應充足，暫無藥品短缺之虞。"
"141","20140623","安博黴素注射劑５００公絲","Ampolin for Injection 500 mg ampicillin/vial","衛署藥製字第001853號","AMPICILLIN SODIUM","500 mg ampicillin per vial/Injection","永豐化學工業股份有限公司","健保停止給付","已於6/30恢復健保價",""
"144","20140226","安挺樂 靜脈點滴注射劑","Actemra Solution for Infusion","衛署菌疫輸字第000907號","Tocilizumab","注射劑","臺灣中外製藥股份有限公司","因有三個批號外盒標示錯誤,標示正確的產品最快要5-6週後才能到台灣,廠商表明3/1起病人之治療將被迫中斷","目前是80 mg/4 ml的外盒標示錯誤，200 mg/10 ml供應正常。",""
"145","20140324","配尼西林Ｖ片４０００００單位","Penicillin V Tablets","內衛藥製字第002479號","Penicillin V pot.","400000U","中國化學製藥股份有限公司","停產或停止進口","可用BICILLIN L-A DISPOSABLE SYRINGE、AMOXICILLIN TRIHYDRATE 替代","Penicillin V適應症為具有感受性之蘭氏陽性菌屬如：肺炎球菌屬、鏈球菌屬、葡萄球菌屬、革蘭氏陰性菌、淋菌性感染等。臨床治療建議可改以抗菌範圍相似之Penicillin G Na inj或Amoxicillin取代。(經詢問廠商已有3年未生產)"
"146","20131105","巴斯德 五合一疫苗(白喉、百日咳、破傷風、小兒麻痺及b型流行性感冒嗜血桿菌疫苗)","PediacelTM","衛署菌疫輸字第000821號","","1 dose/0.5 mL /vial","賽諾菲股份有限公司","廠商表示國外原廠缺貨無法交貨","經評估後，若病人有此自費需求，各醫院可用庫存自費3合1疫苗再加上其他單方疫苗先行替代；此外，國光生技有生產破傷風疫苗，疾管署有批2合1疫苗庫存(破傷風加白喉)可供使用。","供應廠商:國光生技、疾管署"
"147","20140515","喜癒痔栓劑","XYLMOL SUPPOSITORY ＂SINPHAR＂","衛署藥製字第022200號","HYDROCORTISONE ACETATE, LIDOCAINE, ALUMINUM ACETATE, ZINC OXIDE","栓劑","杏輝藥品工業股份有限公司","原物料缺貨","建議使用不同成分但適應症相似替代藥品：JETOO SUPPOSITORIES(明德)與POSULINE SUPPOSITORIES(培力)。","國內有不同成份替代藥品可供使用，暫無醫療上問題。"
"148","20140423","鈣克康靜脈注射液","Calglon","衛署藥製字第058006號","Calcium gluconate 10%","100 mg/ml /amp","永豐化學工業股份有限公司","原料不足","Calglon/Calcium gluconate 10% 主要適應症為鈣的補充劑，可使用其他藥品暫時取代例如:Calcium Chloride","永豐製藥、聯邦製藥廠商告知國外原料商因為台灣進貨量不大，故優先處理其他國家使用，造成貨源不穩無法即時供應。"
"149","20140307","＂景德＂ 凱光錠６００公絲（帕芝奎）","kaicide tablets","衛署藥製字第029833號","PRAZIQUANTEL","600 MG","景德製藥股份有限公司","PIC/S轉換","已恢復供貨","TFDA經全國庫存統計調查後指出:雖庫存可使用時間與使用量均尚未確定，但剩餘存量應可撐過確認是否有代工廠決定承接及製造之日期(7月)。景德已委託衛達生產，8/1正常供貨。"
"150","20140210 20140630","四環黴素眼藥膏","TETRACYCLINE HCL","衛署藥製字第052555號 衛部藥製字第058129號 衛署藥製字第003697號","TETRACYCLINE HCL","眼藥膏","溫士頓醫藥股份有限公司 人人化學製藥股份有限公司 綠洲化學工業有限公司","PIC/S相關","目前人人已通過PIC/S GMP查核",""
"152","20131029","可而爽明眼藥膏","COLSAMIN EYE OINTMENT","衛署藥製字第006187號","NEOMYCIN (SULFATE), DEXAMETHASONE SODIUM PHOSPHATE","點眼膏劑","綠洲化學工業有限公司","廠商缺貨","經評估後，建議以類似成份之改採其他aminoglycoside-corticosteroid的眼藥膏配方",""
"154","20140804","無","Synacthen","專案進口藥品","Tetracosactide Hexaacetate","V/IM 0.25 mg/mL/amp與Depot 1 mg/1 mL/amp","台灣諾華股份有限公司","藥證到期、查驗登記未過或代理權變更","建議另專案進口美國FDA核准用於診斷腎上腺功能不全之其他廠牌的合成ACTH試劑，如 AMPHASTAR PHARMS INC 、MYLAN INSTITUTIONAL、SANDOZ 等品項",""
"162","20150107","恩博針筒裝注射劑","Enbrel 50mg solution for injection in pre-filled syringe","衛署菌疫輸字第 000846 號","ETANERCEPT","50mg/syringe","美商惠氏藥廠（亞洲）股份有限公司台灣分公司","供需不平衡、供貨延遲","已於1/26日回應恢復供貨，無缺藥之虞",""
"163","20150122","＂百合＂ 人白蛋白２０％","ALBIOMIN 20%","衛署菌疫輸字第000380號","HUMAN PLASMA PROTEINS","20% 50mL/bt","禾利行股份有限公司","供需不平衡、供貨延遲","已於104/01/23藥品恢復供應。往後若有短缺之用藥單位，可直接與輔凱張國聖0922-301365聯繫。","輔凱目前進口與供貨穩定，若有Albumin藥品短缺之醫療單位，可直接與該公司聯繫。聯絡人：張國聖0922-301365。"
"164","20140724","腹膜透析液","DIANEAL PERITONEAL DIALYSIS SOLUTION 5L","衛署藥輸字第022199號 衛署藥輸字第022198號 衛署藥輸字第022297號 衛署藥輸字第022299號","SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, DEXTROSE HYDROUS, CALCIUM, CHLORIDE, MAGNESIUM, SODIUM, LACTOSE","透析用液劑","百特醫療產品股份有限公司","原料短缺","有不同規格替代品項可供使用，暫無醫療上問題。","已將詳細內容公佈於藥品短缺資訊網"
"165","20140807","使肺泰100準納乾粉吸入劑","SERETIDE 100 ACCUHALER INHALATION POWDER","衛署藥輸字第023202號","SALMETEROL XINAFOATE MICRONIZED, FLUTICASONE PROPIONATE MICRONIZED","Salmeterol 50 mcg; Fluticasone 100 mcg","GSK","因換廠導致產能不足","以該公司同成分不同劑型品項取代","目前國內此類藥品(Salmeterol+Fluticasone)吸入劑型皆為同一家廠商生產(經查該品因新廠尚未供貨，目前以舊包裝專案進口，應無短缺虞慮)"
"166","20140519","賀癌平凍晶注射劑４４０公絲","HERCEPTIN","衛署菌疫輸字第000625號","TRASTUZUMAB","凍晶注射劑","羅氏大藥廠股份有限公司","供需不平衡、供貨延遲","於藥品尚未空運來台期間，羅氏藥廠將主動協調該藥品之供應，確保每一位病人就醫用藥之權利。如需協助藥品供應，請洽羅氏呂雯榆經理 Phone: (02)25446610 email: lydia.lu@roche.com","2/25經詢問後廠商表示已能穩定供貨"
"167","20140206","優可注射液１公絲/公撮（唯克斯汀）","Leuka inj 1 mg/ml","衛署藥製字第029529號","VINCRISTINE SULFATE","1 mg/ml","優良化學製藥股份有限公司","廠商缺藥，無法正常供應所有需要的醫院","赫士睿(代理經銷商大用公司)已進口一批vincristine針劑，約4-7天內可出貨，約可供應國內半年所需。","104/2/25詢問赫士睿後確認供貨無虞"
"168","20150209","紐奧黴素膠囊２５０公絲","NEOMYCIN CAPSULES 250MG","衛署藥製字第 011518 號","Neomycin","250/Cap","順華藥品工業股份有限公司","與PIC/S相關","順華藥品公司已通過PIC/S認證，並無斷貨之虞。","經與順華藥品公司再確認其已於103年10月16日通過PIC/S認證，並無斷貨之虞。"
"169","20150209","舒眼康眼用懸浮液","Fluzocon Eye Drops","衛署藥製字第 049530 號","Fluorometholone Tetrahydrozoline","0.1%&0.025%/Eye Drops","溫士頓醫藥股份有限公司","與PIC/S相關","溫士頓藥品公司已於103年12月底通過PIC/S認證。","經與溫士頓藥品公司聯繫，確認已於103年12月底通過PIC/S認證，0.02%/5ml規格會短期缺貨，但0.02%/10ml及0.1%之規格並未斷供，可穩定供貨。"
"170","20150212","化痰能膠囊２００毫克（乙醯半胱胺酸）","FLUTAFIN CAPSULE 200MG (ACEFYLOYSTEINE)","衛署藥製字第030873號","Acetylcysteine","200mg/Cap","西德有機化學藥品股份有限公司","與PIC/S相關","建議以同成分、劑型、規格藥品ACETIN CAPSULES 200MG(藥證:衛署藥製字第025939號)替代使用，亦可改用其他同成分口服劑型。","目前國內生產Acetylcystein 200mg膠囊劑型僅剩一家製造廠-臺裕化學製藥廠股份有限公司，公司已通過PIC/S貨源充足且持續供應"
"171","20140807","普留淨注射劑","Proleukin for injection","衛署菌疫輸字第000650號","Aldesleukin","Aldesleukin 18 X 106 IU/凍晶乾燥注射劑","台灣諾華股份有限公司","國外廠房遷廠而無法供應藥品","104/3/5經詢問後表示已恢復供貨","目前國內無其他廠商在供應aldesleukin。"
"172","20150209","得立生錠（的剎美剎松）","DORISON TABLETS (DEXAMETHASONE) ＂ROYAL＂","衛署藥製字第 019643 號","Dexamethasone","4mg per Tab./TAB","皇佳化學製藥股份有限公司","與PIC/S相關","建議使用符合PIC/S之國內藥廠如生達、永信、杏輝、中化等所生產之同成分不同劑量之口服藥錠進行取代使用。","皇佳已過PIC/S，經3/6詢問後確定無缺藥之虞。"
"173","20150209","佳鉑帝靜脈注射液","PARAPLATIN IV INJECTION","衛署藥輸字第024074號","Carboplatin","450MG (1VLX45ML)/靜脈注射液","台灣必治妥施貴寶股份有限公司","生產線整合及安排","請尋求其他仍在供貨的同含量劑型(45 mL/vail)廠商進行替代，或可使用同廠商15 mL/vial暫代。","必治妥施貴寶的15 mL/vial劑型並無短缺，可作為短缺品項(45 mL/vial)替代使用。 若一定要45 mL/vail之包裝亦有其他廠商供應，且皆有45 mL及15 mL之劑型可供選用。"
"175","20140804","彼洛喜錠","Procid","衛署藥製字第007256號","Probenecid","500mg/tab","強生化學製藥廠股份有限公司","原料短缺","待原料恢復供應後公司評估市場需求，可再恢復生產probenecid","於104年4月7日詢問廠商後確認已恢復正常供貨"
"184","20150109","","Verorab","無","Inactivated Rabies Virus","2.5IU/vial 、0.5ml/dose","賽諾菲股份有限公司","藥證到期、查驗登記未過或代理權變更","1045/8已公告無缺藥之虞",""
"174","20150212","壓得疏靜脈輸注劑","SODIUM NITROPRUSSIDE FOR INTRAVENOUS INFUSION ＂DBL＂","衛署藥輸字第021879號","Nitroprusside","50mg/2ml/Inj","Hospira","停產或停止進口","預計104年3月至4月輸入到貨，建議短缺期間先以替代藥物治療，後續持續追蹤Nitroprusside到貨進度。","此為藥品訂貨進藥銜接時程而致的短缺問題，目前無缺藥"
"176","20150402","肌弛適　注射液２公絲/公撮","NIMBEX INJECTION 2MG/ML","衛署藥輸字第022770號","CISATRACURIUM BESYLATE","10mg/5ml/amp","荷商葛蘭素史克藥廠台灣分公司","供需不平衡、供貨延遲","104/04/09電聯葛蘭素史克藥廠股份有限公司，該公司Nimbex(cisatracurium)注射劑仍有庫存可正常供貨，無缺藥之疑慮。","若於缺貨時改以不同成分類似藥理作用之Atracurium替代使用(共計2張效期內持續供應藥品許可證)，免於醫療中斷。"
"177","20150423","達爾能持續性膠囊120毫克","Diltelan","衛署藥製字第048128","DILTIAZEM HYDROCHLORIDE","Capsules 120mg","友華生技醫葯股份有限公司","供需不平衡、供貨延遲","建議使用同成分同劑型有Progor 120mg/cap(天義企業)、Nakasser SR 120m/cap(南光製藥)","結案"
"178","20150428","力必平持續性藥效膜衣錠2毫克","Requip PD 2mg Prolonged Release Tablet","衛署藥輸字第025118號","ROPINIROLE HYDROCHLORIDE","2 mg","荷商葛蘭素史克藥廠股份有限公司台灣分公司","供需不平衡、供貨延遲","經與負責此藥品之廠商產品經理(Jenet)連絡後表示，Requip之原料於4/6-4/17曾有短缺的情況，導致廠商將藥品優先供貨於醫療院所，進而導致一般藥局有缺藥之情況，但此問題已於4/20後解決，目前並無原料或藥品短缺之情況。","目前已無原料或藥品短缺之情形"
"179","20150428","維諾拜注射液","Vinelbine Injection","衛署藥輸字第025489號","VINORELBINE TARTRATE","10mg/ml","台灣費森尤斯卡比股份有限公司","生產線整合及安排","另有其他廠商供應Vinelbine 10mg/vial及50mg/vial(如許可證資料)，故現無藥品短缺之虞。","此藥品為費森尤斯卡比公司製造，昱昇廠商為其物流供應商，經與費森尤斯卡比聯繫，其因今年4月份更換物流供應商為大昌華嘉，不由昱昇廠商配送，故實際並無藥品供應短缺問題。"
"180","20150209","＂景德＂雙羥??注射液２毫克/毫升","MITOXANTRONE INJECTION 2MG/ML ＂KINGDOM＂","衛署藥製字第033445號","Mitoxantrone","20mg,10ml/vial","景德製藥股份有限公司","因Mitoxantrone 20mg,10ml/vial持續性安定性試驗檢驗結果中不純物限量項目不符合規格,衛福部公告回收","104/55詢問景德後，表示可正常供貨。","除了mitoxantrone之外，尚有其他藥物可供臨床選用。"
"181","20150312","宜保安濃縮輸注液1毫克/毫升","Evoltra concentrate for solution for infusion","衛署藥輸字第025472號","Clofarabine","1mg/ml / concentrate for solution for infusion","賽諾菲股份有限公司","與PIC/S相關","104/5/5賽諾菲已恢復供貨。","如有短缺建議以其他成份藥品供臨床醫療選擇(包括Everolimus+hyper-CVAD、CAG regimen 等) 多種治療模式。"
"182","20150312","“國血製劑益康”(20%)人血清白蛋白注射劑","＂TBSF＂ (20%) Human Albumin Solution","衛署菌疫輸字第000842號","HUMAN ALBUMIN","20% 50mL/bt","醫療財團法人台灣血液基金會","供需不平衡、供貨延遲","104年5月確認已可解除短缺狀態。","經詢問各家廠商後得知目前Albumin廠商供應時間及數量皆很不穩定，大部份皆給合約廠商。"
"183","20140819","高卡路里輸液一號（開始液）","HICALIQ-1 ＂TERUMO＂","衛署藥輸字第009502號","POTASSIUM ACETATE, GLUCOSE, MAGNESIUM SULFATE, POTASSIUM PHOSPHATE MONOBASIC, CALCIUM GLUCONATE, ZINC SULFATE","注射劑","日商泰爾茂股份有限公司台北分公司","藥證到期、查驗登記未過或代理權變更","有替代藥品使用，暫無醫療上問題。","輸液的種類繁多，日商泰爾茂公司的高卡路里輸液，雖領有藥證。經與廠商確認後，廠商表示使用完畢後即斷貨。目前未有繼續生產的規劃。"
"185","20150415","＂瑪科隆＂佳立鈣錠500毫克","A-Cal Tablets 500mg ＂MACRO＂","衛署藥製字第057816號","CALCIUM CARBONATE","500mg/Tab","瑪科隆股份有限公司","供需不平衡、供貨延遲","104/5/8確認無缺藥之虞","由於calcium carbonate缺藥乃受原料藥不符藥品等級之影響，建議應追蹤廠商改善情形與可恢復正常供貨時程。"
"186","20150430","＂生達＂ 普治使可注射液（普斯克）","BUTYLSCOPOLAMINE BROMIDE","衛署藥製字第019505號","SCOPOLAMINE BROMOBUTYLATE","注射劑","生達化學製藥股份有限公司","停產或停止進口","有其他廠牌提供之同成分、同劑型、同劑量藥品替代使用","其他廠牌同成分規格藥品目前穩定供貨的藥廠有大豐製藥股份有限公司、壽元化學工業股份有限公司、南光化學製藥股份有限公司 、安星製藥股份有限公司，而永信藥品工業股份有限公司則可以從五月中起穩定供貨。"
"187","20150325","利蝨洗液（苯甲醯？酯）","B.B. LOTION ＂W.P.＂ (BENZYL BENZOATE)","衛署藥製字第039215號","BENZYL BENZOATE","100mL/BT","華盛頓製藥廠股份有限公司","與PIC/S相關","目前國內人人化學製藥公司仍有生產含同成份、同劑量、同劑型之外用液劑-疥寧洗劑 (Jalin lotion, 25% 150ml)，可做為替代用藥品項。","華盛頓製藥廠因尚未通過PIC/S認證，故無法供應滅疥洗液(Benzyl benzoate)。國內有其他家藥廠生產類似外用液劑，可做為替代使用。"
"188","20150327","＂景德＂息疥軟膏（γ－六氯苯）","SCABI CREAM (GAMMA-BHC) ＂KINGDOM＂","衛署藥製字第020964號","LINDANE","1% 10g/Tube","景德製藥股份有限公司","供需不平衡、供貨延遲","建議原通報單位逕向廠商了解供貨延遲之原因，如其無法達成供應穩定需求，建議可更換其他同成份品項使用。","依其有效成份(LINDANE)搜尋藥證，另有同劑型衛署藥製字第044252號一項，乳劑劑型衛署藥製字第010292號一項。(另內衛成製字第000538號複方軟膏劑標記不得製造)。"
"189","20150126","利度膚寧注射液","LIDOPHRINE INJECTION","內衛藥製字第005470號","EPINEPHRINE (ADRENALINEPIRENAMINE), LIDOCAINE HCL","20ML/VIAL","東洲化學製藥廠股份有限公司","與PIC/S相關","國內同成分藥品皆為小包裝（1-1.8 mL/支)，所含濃度略有差異但應不致於影響麻醉效果，主要供牙科使用。若需較大劑量，建議可以lidocaine及epinephrine單方藥品合併使用替代。","除牙科外，外科系別可能使用較大劑量，現有供應之藥品皆為小包裝，考慮使用方便性與成本，建議以單方藥品合併使用。"
"190","20150209","＂派頓＂ 愛樂淨外用液４％（克羅希西汀）","AIPISCRUB EXTERNAL SOLUTION 4%","衛署藥製字第036764號","CHLORHEXIDINE","4% 4000mL/solution","台灣派頓化學製藥股份有限公司","與PIC/S相關","有其他家藥廠生產含同成份之外用液劑替代。","台灣派頓公司由於目前尚未通過PIC/S故無法生產，預計104年3月後才可能復工製造。國內有其他家藥廠生產類似外用液劑，可做為替代使用。"
"191","20141013","益滋＂ 愛其地散","E-Z-HD","衛署藥輸字第023118號","barium sulfate","98%, 340 g/box-散劑","禾利行股份有限公司","停產或停止進口","建議以以下藥品替代: 鋇脫普液－１２０200mL/bag(金源貿易)、Barium sulfate 96% 派可散 10kg/pc (禾利行)","此次通報主要問題在於濃度不足，顯影不清上。而濃度不同的考量，在不同醫療院所間具有較大差異。已將此訊息告知禾利行，協助了解濃度不足的處理方式，惟禾利行無法在時間內回覆，會持續了解。禾利行確定不再代理進口E-Z-HD for Suspension/barium sulfate ，全面改用Barium sulfate 96% 10kg/pc的品項。"
"192","20150428","＂杏輝＂可立舒軟膏0.5毫克/公克（可洛貝他索）","CLOBETASOL OINTMENT 0.5MG/GM ＂SINPHAR＂","衛署藥輸字第028562號","CLOBETASOL-17-PROPIONATE","7gm/Tu","杏輝藥品工業股份有限公司","生產線整合及安排","台灣領有該成分藥證的許可證共有184張，如醫院有斷藥之虞，可聯絡寶齡富錦、井田製藥(僅生產20克)、永勝藥品(僅生產7克)、政德製藥等藥商可立即供貨。","本通報短缺藥品clobetasol軟膏7GM/TUBE係由杏輝出產，經聯絡杏輝確認是由於原料供貨問題，最快預計5/11方能恢復供貨。目前供貨端仍在處理中，故無法完全確定5/11可如期恢復生產線。經調查了解同劑量成份同劑型有多家廠牌可供採購，應無醫療中斷之虞。"
"193","20150428","＂杏輝＂ 杏聯軟膏","SINQUART CREAM ＂SINPHAR＂","衛署藥製字第019615號","IODOCHLORHYDROXYQUIN, GENTAMICIN (AS SULFATE), BETAMETHASONE 17-VALERATE, TOLNAFTATE","10gm/Tu","杏輝藥品工業股份有限公司","生產線整合及安排","建議使用同成分同劑型之藥品（藥製020998）","確認國內同成分同劑型有BEGTI CREAM (生達化學製藥)，建議醫院逕與生達化學製藥聯繫購買，無需啟動缺藥處理機制。"
